Tag: supplements

Once a niche treatment for Type 2 diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists are rapidly evolving from therapeutic agents to a transformative force across multiple industries. In 2024, an estimated 1 in 8 American adults, translating to over 30 million individuals, reported using GLP-1 medications such as Ozempic, Wegovy, and Mounjaro, according to data from…

GRANTS PASS, OR – A catastrophic fire swept through Oshala Farm, a prominent herbal producer and bulk ingredient supplier, on Tuesday afternoon, July 8, 2026, resulting in the complete destruction of its warehousing and drying facilities. The blaze also consumed the farm’s extensive inventory of dried herbs, some of which represent years of dedicated cultivation…

The botanical supplement industry is undergoing a profound transformation, driven by escalating consumer demand for transparency and an unwavering focus on product quality. A pivotal 2025 supplement consumer survey conducted by the Industry Transparency Center has illuminated this shift, revealing that shoppers now prioritize detailed ingredient information and credible quality seals above almost all other…

In the wake of a pivotal March 2026 meeting convened to "explore the scope of dietary supplement ingredients," the U.S. Food and Drug Administration (FDA) has opened a significant period for public comment. This initiative, designed to solicit industry and public input, has already garnered an overwhelming response, with 952 distinct submissions flooding the agency’s…

A groundbreaking randomized, double-blind, placebo-controlled clinical trial has provided robust scientific validation for the efficacy of Dose for Cholesterol, a popular liquid dietary supplement. Published in the esteemed Journal of Dietary Supplements, the study reveals that participants consuming the supplement experienced a substantial and statistically significant decrease in low-density lipoprotein (LDL) cholesterol levels over a…

Sabinsa’s global CEO and managing director, Shaheen Majeed, unequivocally positions quality, transparency, and sustainability as foundational pillars for the company’s approach to ingredient manufacturing and innovation. In a recent discussion with Devon Gholam, editor of SupplySide Supplement Journal, Majeed articulated how this "quality-first" ethos permeates every stage of an ingredient’s lifecycle, from its origin on…

A groundbreaking new paper, published in the esteemed journal Progress in Lipids Research, is shedding new light on the intricate mechanisms by which dietary interventions influence the human endocannabinoidome, a sophisticated lipid signaling network that plays a pivotal role in regulating metabolic, immune, and neurobehavioral processes. This comprehensive review, a synthesis of over 140 individual…

A comprehensive new review published in the esteemed journal Frontiers in Aging has illuminated the significant potential of omega-3 fatty acid supplementation, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in promoting healthy aging. The research, conducted by a collaborative team of scientists from institutions in Greece and Cyprus, centers on the capacity of these…

The global supplement industry is currently confronting a complex web of challenges, with persistent supply chain disruptions and a growing scarcity of key resources amplifying existing concerns. These intertwined issues necessitate a strategic re-evaluation of ingredient procurement, formulation practices, and the overarching commitment to sustainability. Recognizing the critical nature of these challenges, SupplySide Supplement Journal…

The supplement industry, a dynamic landscape of scientific innovation and consumer-driven demand, is once again under the microscope. Recent developments highlight critical concerns regarding product authenticity, particularly with ubiquinol supplements, alongside emerging research pointing to the performance-enhancing benefits of beetroot. This edition of Supplement Shorts delves into these key stories, examining the implications for both…